Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement

Seminars in Arthritis and Rheumatism · Published 2026-06-19 · DOI 10.1016/j.semarthrit.2026.153026

Free full text

Authors (35)

Dorthe B. Berthelsen, Ben Horgan, Lee Simon, John P.A. Ioannidis, Niti Goel, Peter Tugwell, Erin Balay-Dustrude, Susan J. Bartlett, Clifton O. Bingham, Maarten Boers, Coralie Bouillot, Peter Böhm, Ernest Choy, Mary Cowern, Krista Dagsvik, Chris Djurtoft, Daniel E. Furst, Tobias Haugegaard, Glen S. Hazlewood, Alison M. Hoens, Tanja Schjødt Jørgensen, Shannon E. Kelly, Denise Kruzikas, Joachim Musaus, Pam Richards, Beverly J. Shea, Vibeke Strand, Megan Thomas, Karina Torralba, Marieke Voshaar, Max Weinbrecht-Mischkewitz, Thasia G. Woodworth, Grace Wright, Caroline Flurey, Robin Christensen

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Berthelsen, D., Horgan, B., Simon, L., et al. (2026). Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement. Seminars in Arthritis and Rheumatism. https://doi.org/10.1016/j.semarthrit.2026.153026

Related articles